- Research works
- 70 ▼ 26% vs 2018-21
- Citations
- 5k 71.1 per fractional work
- Top-10% rate
- 17.2% all institutions 10.0%
- Open access
- 35% world 40%
- International
- 25% world 18%
Not ranked overall: Curis (United States) is under the volume floor below which a citation excellence rate is noise. Not ranked is not the same as ranked last.
Which fields of science does Curis (United States) work in?
In all years, 62% of research at Curis (United States) is in Life Sciences, 35% in Health Sciences. Its largest fields are Biochemistry, Genetics and Molecular Biology (52%), Medicine (34%), Immunology and Microbiology (5%). It does 3.4× the world's share of Life Sciences.
Each ring splits the one inside it: the four domains of science, their fields, their subfields. Size is fractional works in all years. Every slice is a page; the interactive view zooms down to single topics and colours each by how much more of it this institution does than the world.
Its 3 domains and 13 fields, with their numbers
- Life Sciences4361.9%
- Health Sciences2535.3%
- Medicine2433.8%
- Health Professions11.3%
- Dentistry00.1%
- Nursing00.0%
- Physical Sciences22.9%
- Environmental Science11.5%
- Mathematics00.5%
- Engineering00.5%
- Chemistry00.2%
- Computer Science00.2%
Field profile
Location quotient across every field it publishes in: outside the ring is more than an institution of this size would be expected to publish, inside it is less.
Rings at 0.5×, 1× and 2×. Widest outward: Immunology and Microbiology, 8.9×. Every wedge is a field page.
All 8 fields, with their numbers
- Immunology and Microbiology8.95×1 works
- Pharmacology, Toxicology and Pharmaceutics5.66×0 works
- Medicine3.58×6 works
- Biochemistry, Genetics and Molecular Biology2.90×1 works
- Mathematics1.69×0 works
- Neuroscience0.61×0 works
- Chemistry0.54×0 works
- Engineering0.05×0 works
Who are the top researchers at Curis (United States)?
Ranked on the quality score, Cheng-Jung Lai, Robert N. Booher and Ruzanna Atoyan lead among researchers whose main affiliation is Curis (United States).
- 1
Cheng-Jung Lai
United States · #392,953 worldwide 2.4k citations · 63 works
- 2
Robert N. Booher
United States · #517,338 worldwide 2.6k citations · 18 works
- 3
Ruzanna Atoyan
United States · #554,830 worldwide 1.7k citations · 67 works
- 4
Rudi Bao
United States · #604,437 worldwide 1.8k citations · 54 works
- 5
Reinhard von Roemeling
United States · #712,391 worldwide 3.1k citations · 109 works
- 6
Da-Gong Wang
United States · #767,434 worldwide 1.3k citations · 23 works
- 7
Hui Qu
United States · #791,635 worldwide 1.8k citations · 60 works
- 8
Steven DellaRocca
United States · #935,651 worldwide 805 citations · 35 works
- 9
Maria Samson
United States · #1,015,279 worldwide 2k citations · 74 works
- 10
Changgeng Qian
United States · #1,056,126 worldwide 1.8k citations · 69 works
Which keywords describe research at Curis (United States)?
By fractional works in all years, weighted toward what it does more of than the world: Cancer Therapy, Cancer, Stem Cells, Tumorigenesis, Development, Transcriptional Regulation, Gene Expression and Pancreatic Cancer.
- HIF-1
- Pattern Recognition Receptors
- Fibroblast Activation Protein
- Proteasome Inhibitors
- Classification
- Immunosuppression
- DNA Methylation
- Immunotherapy
- Chemotherapy
- Angiogenesis
- Rituximab
- Inflammation
- PROTACs
- Histone Deacetylases
- Tumor Microenvironment
- Pathway Inhibition
- Hedgehog Signaling
- Transcriptional Regulation
- Tumorigenesis
- Cancer
- Cancer Therapy
- Stem Cells
- Development
- Gene Expression
- Pancreatic Cancer
- Epigenetic Regulation
- HDAC Inhibitors
- BET Bromodomains
- PET Imaging
- Prognostic Factors
- Innate Immunity
- Lymphoma
- NF-?B Activation
- Targeted Therapy
- Histone Modification
- Cancer Progression
- Molecular Profiling
- Cell Death
- N-terminal Acetylation
- Therapeutic Targets
Size is fractional works in all years in the topics tagged with each word; colour is the word's share of this institution's work against its share of the world's. The 40 words are chosen for being large and distinctive. Each links to the topic it comes from most.
All 40 words, with their numbers
- Cancer Therapy12▲ 26×7 topics
- Cancer9▲ 9.2×14 topics
- Stem Cells8▲ 36×6 topics
- Tumorigenesis7▲ 183×3 topics
- Development7▲ 29×4 topics
- Transcriptional Regulation7▲ 39×6 topics
- Gene Expression6▲ 14×4 topics
- Hedgehog Signaling6▲ 222×1 topic
- Pancreatic Cancer6▲ 69×2 topics
- Pathway Inhibition6▲ 455×1 topic
- Epigenetic Regulation6▲ 37×2 topics
- Tumor Microenvironment6▲ 23×5 topics
- HDAC Inhibitors6▲ 408×1 topic
- Histone Deacetylases6▲ 408×1 topic
- BET Bromodomains5▲ 341×1 topic
- PROTACs5▲ 341×1 topic
- PET Imaging4▲ 28×3 topics
- Inflammation4▲ 2.5×17 topics
- Prognostic Factors3▲ 11×5 topics
- Rituximab3▲ 29×2 topics
- Innate Immunity3▲ 11×4 topics
- Angiogenesis3▲ 8.9×4 topics
- Lymphoma3▲ 25×2 topics
- Chemotherapy2▲ 4.8×6 topics
- NF-?B Activation2▲ 64×2 topics
- Immunotherapy2▲ 5.0×9 topics
- Targeted Therapy2▲ 14×3 topics
- DNA Methylation2▲ 24×1 topic
- Histone Modification2▲ 43×1 topic
- Immunosuppression2▲ 24×2 topics
- Cancer Progression2▲ 12×6 topics
- Classification2▲ 7.3×1 topic
- Molecular Profiling2▲ 22×1 topic
- Proteasome Inhibitors2▲ 39×2 topics
- Cell Death2▲ 13×4 topics
- Fibroblast Activation Protein2▲ 51×1 topic
- N-terminal Acetylation2▲ 51×1 topic
- Pattern Recognition Receptors2▲ 17×2 topics
- Therapeutic Targets2▲ 10×2 topics
- HIF-12▲ 32×1 topic
Which research topics does Curis (United States) publish most on?
By volume in 2022-now: Cancer Immunotherapy and Biomarkers, Acute Myeloid Leukemia Research, Lymphoma Diagnosis and Treatment and Cytokine Signaling Pathways and Interactions.
Area is fractional works; colour is the subfield each topic belongs to.
- 1 Cancer Immunotherapy and Biomarkers Oncology 1 works
- 2 Acute Myeloid Leukemia Research Hematology 1 works
- 3 Lymphoma Diagnosis and Treatment Pathology and Forensic Medicine 0 works
- 4 Cytokine Signaling Pathways and Interactions Oncology 0 works
- 5 Chronic Lymphocytic Leukemia Research Genetics 0 works
- 6 CAR-T cell therapy research Oncology 0 works
- 7 CNS Lymphoma Diagnosis and Treatment Neurology 0 works
- 8 Glioma Diagnosis and Treatment Genetics 0 works
- 9 Immune Response and Inflammation Immunology 0 works
- 10 Inflammatory mediators and NSAID effects Pharmacology 0 works
How open and international is its research?
Against the world's own shares: the tick on each track. Both are shares of its output, so they sit on one scale and can be read against each other as well as against the world.
World: 40% of research is openly available.
World: 18% is written across borders.
How has Curis (United States)'s research output changed?
Output in 2022-2025 was 26% lower than in 2018-2021.
The same series as a ribbon: one cell per year, darker for more. The line above answers how much; this answers when.
Its share of all research
Growing output can still be a shrinking share: all of science grows. This is Curis (United States) as a percentage of every work published that year, 0.000030% in 2024.
Fractional works of Curis (United States) over all fractional works that year. How the balance of science has shifted.
Other research institutions in Lexington
- Institute for Learning and Development
- Atmospheric and Environmental Research
- Inotek Pharmaceuticals (United States)
- Biostatistical Consulting (United States)
- Cubist Pharmaceuticals (United States)
- Ocean Acoustical Services and Instrumentation Systems (United States)
- Boston Collaborative Drug Surveillance Program
- Synta Pharmaceuticals (United States)
Research measures only: rankings here say nothing about teaching, admissions or student experience. Comparable institutions and collaboration partners have tabs of their own, above.
Discussion
Ask a question or share a note about Curis (United States). Keep it to the research: no personal attacks, advertising or links. Any reader can report a post, which collapses it for everyone until it is opened.